loadpatents
name:-0.013702869415283
name:-0.0077719688415527
name:-0.0055179595947266
KIM; Won Jeoung Patent Filings

KIM; Won Jeoung

Patent Applications and Registrations

Patent applications and USPTO patent grants for KIM; Won Jeoung.The latest application filed is for "imidazopyridine derivative compounds and use of same".

Company Profile
4.8.14
  • KIM; Won Jeoung - Hwaseong-si KR
  • Kim; Won Jeoung - Suwon-si KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Imidazopyridine Derivative Compounds And Use Of Same
App 20220098205 - BAE; In Hwan ;   et al.
2022-03-31
Pyrazole derivative compound and use thereof
Grant 11,254,676 - Bae , et al. February 22, 2
2022-02-22
Pyrazole Derivative Compound And Use Thereof
App 20210009591 - BAE; In Hwan ;   et al.
2021-01-14
Imidazopyridopyrimidine derivative compound and use thereof
Grant 10,696,675 - Lee , et al. June 30, 2
2020-06-30
Novel Heterocyclic Derivative Compound And Use Thereof
App 20190152973 - LEE; Moon Sub ;   et al.
2019-05-23
Bicyclic derivatives and pharmaceutical composition including the same
Grant 9,828,366 - Kim , et al. November 28, 2
2017-11-28
Bicyclic Derivatives And Pharmaceutical Composition Including The Same
App 20170066750 - KIM; Ji Sook ;   et al.
2017-03-09
Novel Pyrimidine Derivative And Pharmaceutical Composition Including Same As An Active Ingredient
App 20140163226 - Park; Chul Hyun ;   et al.
2014-06-12
Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
Grant 8,586,752 - Ha , et al. November 19, 2
2013-11-19
Crystalline S-omeprazole Strontium Hydrate, Method For Preparing Same, And Pharmaceutical Composition Containing Same
App 20130303772 - HA; Tae Hee ;   et al.
2013-11-14
Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
Grant 8,513,426 - Ha , et al. August 20, 2
2013-08-20
Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
Grant 8,106,076 - Ha , et al. January 31, 2
2012-01-31
Crystalline S-omeprazole Strontium Hydrate, Method For Preparing Same, And Pharmaceutical Composition Containing Same
App 20110046383 - HA; Tae Hee ;   et al.
2011-02-24
Process For Preparing Bepotastine And Intermediates Used Therein
App 20100168433 - Ha; Tae Hee ;   et al.
2010-07-01
Novel Crystalline Bepotastine Metal Salt Hydrate, Method For Preparing Same, And Pharmaceutical Composition Comprising Same
App 20100137367 - Ha; Tae Hee ;   et al.
2010-06-03
Crystalline S-Omeprazole Strontium Hydrate, Method For Preparing Same, And Pharmaceutical Composition Containing Same
App 20090258908 - HA; Tae Hee ;   et al.
2009-10-15
Pharmaceutical Composition Containing Clopidogrel Camphorsulfonate Or Polymorphic Forms Thereof
App 20090209576 - Kim; Won Jeoung ;   et al.
2009-08-20
Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
Grant 7,576,219 - Ha , et al. August 18, 2
2009-08-18
Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
App 20070093533 - Ha; Tae Hee ;   et al.
2007-04-26
Antiresorptive mutual salt of raloxifene and bisphosphonic acid
App 20070082871 - Ha; Tae Hee ;   et al.
2007-04-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed